510(k) Report

510(k) · Cleared

Cleared

Urine Drug Screening Control

K992395510(k) TraditionalCleared Aug 26, 199938-day reviewClass I21 CFR 862.3280

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Seracare Technology · DIF Drug Mixture Control Materials

Cleared on Aug 26, 1999 as substantially equivalent to K971691 (Bio-Rad, 1997) after a 38-day review. Its family tree reaches back 2 generations to 1990.

Decided
Aug 26, 1999
Review
38 days
Class
Class I
Product code
DIF
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K903430 (1990). No later device cites it as a predicate yet.

  1. Root · 2 generations backK903430 Liquichek CK/LD Isoenzyme Control; Levels 1 and 2Bio-Rad · 1990
  2. 1 generation backK971691 Liquichek Urine Toxicology Control - Level S1, S2, S3Bio-Rad · 1997
  3. This deviceK992395 Urine Drug Screening ControlSeracare Technology · 1999
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K903430Liquichek CK/LD Isoenzyme Control; Levels 1 and 2Bio-Rad1990—
−1K971691Liquichek Urine Toxicology Control - Level S1, S2, S3Bio-Rad1997—
0 (this device)K992395Urine Drug Screening ControlSeracare Technology1999—
FIG. 1 — Lineage of K992395, 1990–1999Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DIF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K971691Liquichek Urine Toxicology Control - Level S1, S2, S3
Summary page 1
…| , Product code: DIF 21 CFR 862:3280 : Quality Control Material (Assayed and Unassayed) Predicate device: LIQUICHEK™ URINE TOXICOLOGY CONTROLS BIO-RAD Laboratories K-971691 Device description: Urine Drug Screening Control is designed to monitor the performance of screening, semi-quantitative and con…
Bio-Rad1997—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 9 years and passes through 2 companies; a new generation was cleared every 6.8 years on median.
  • None of the 2 ancestors has a recall.

How does its category compare?

All DIF devices

DIF Drug Mixture Control Materials: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DIF

1in 2016

2007: 12008: 22010: 12011: 12012: 32013: 22016: 1
2007high 3 (2012) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DIF

35in 2012

2012: 35 days median
2007high 35 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DIF

1in 2021

2011: 12013: 12017: 52021: 1
2007high 5 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DIF

1in 2016

2011: 12012: 32016: 1
2007high 3 (2012) · low 0 (2007)2025

MAUDE reports naming product code DIF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—00
20090—00
20101—00
20111—11
201233503
20132—10
20140—00
20150—00
20161—01
20170—50
20180—00
20190—00
20200—00
20210—10
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

Urine Drug Screening Control is a liquid human urine based assayed quality control material intended to monitor the performance of screening, semi-quantitative and confirmatory drug-of-abuse testing procedures.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K992395: Urine Drug Screening Control.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K992395

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026